Ibrutinib 11014-0397
Product NDC
11014-0397- Manufacturer
- Catalent Pharma Solutions, Llc
- Dosage Form
- Tablet, Film Coated
- Product Type
- Drug For Further Processing
- Marketing Start
- February 16, 2018
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ibrutinib | 420 mg/1 |
Packaging Options(1)
1 BAG in 1 CONTAINER (11014-0397-2) / 41667 TABLET, FILM COATED in 1 BAG